References
- Behçet H. Über rezidivierende, aphtöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatologische Wochenschr. 1937;105:1152–1163.
- Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Altunbas HH, Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138:373–380. doi:https://doi.org/10.1016/j.ajo.2004.03.022.
- Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K. The eighth Frederick H. Verhoeff Lecture, presented by Saiichi Mishima, MD. Behcet’s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc. 1979;77:225–279.
- Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Behçet disease: evolution of clinical manifestations. Medicine (Baltimore). 2011;90:125–132. doi:https://doi.org/10.1097/MD.0b013e318211bf28.
- Deuter CM, Kötter I, Wallace GR, Murray PI, Stübiger N, Zierhut M. Behcet’s disease: ocular effects and treatment. Prog Retin Eye Res. 2008;27:111–136. doi:https://doi.org/10.1016/j.preteyeres.2007.09.002.
- Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici H. Target organ associations in Turkish patients with Behçet’s disease: a cross sectional study by exploratory factor analysis. J Rheumatol. 2002;29:2393–2396.
- International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet. 1990;335:1078–1080.
- International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338–347. doi:https://doi.org/10.1111/jdv.12107.
- Mason RM, Barnes CG. Behçet’s syndrome with arthritis. Ann Rheum Dis. 1969;28:95–103. doi:https://doi.org/10.1136/ard.28.2.95.
- O’Duffy JD, Goldstein NP. Neurologic involvement in seven patients with Behçet’s disease. Am J Med. 1976;61:170–178. doi:https://doi.org/10.1016/0002-9343(76)90166-2.
- Behçet’s Disease Research Committee of Japan. Behçet’s disease: a guide to diagnosis of Behçet’s disease. Jpn J Ophthalmol. 1974;18:291–294.
- Dilsen N, Konice M, Aral O. Our diagnostic criteria for Behçet’s disease—an overview. In: Lehner T, Barnes CG, eds. Recent Advances in Behçet’s Disease. International Congress and Symposium Series. London, UK: London Royal Society of Medicine Services; 1986:177–180.
- Aggarwal R, Ringold S, Khanna D, et al. Distinctions between diagnostic and classification criteria? Arthritis Care Res (Hoboken). 2015;67:891–897. doi:https://doi.org/10.1002/acr.22583.
- Hatemi G, Christensen R, Bang D, et al. update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis. 2018;2018(77):808–818.
- Taylor SR, Singh J, Menezo V, Wakefield D, McCluskey P, Lightman S. Behçet disease: visual prognosis and factors influencing the development of visual loss. Am J Ophthalmol. 2011;152:1059–1066. doi:https://doi.org/10.1016/j.ajo.2011.05.032.
- Keino H, Okada AA, Watanabe T, Nakayama M, Nakamura T. Efficacy of infliximab for early remission induction in refractory uveoretinitis associated with Behçet disease: A 2-year follow-up study. Ocul Immunol Inflamm. 2017;25:46–51. doi:https://doi.org/10.1080/09273948.2016.1239746.
- Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121:785–796. doi:https://doi.org/10.1016/j.ophtha.2013.09.048.
- Taylor WJ, Fransen J. Distinctions between diagnostic and classification criteria: comment on the article by Aggarwal et al. Arthritis Care Res (Hoboken). 2016;68:149–150. doi:https://doi.org/10.1002/acr.22671.
- Loh WY. Classification and regression trees. WIREs Data Mining Knowl Discov. 2011;1:14–23. doi:https://doi.org/10.1002/widm.8.
- Grimes DA, Schulz KF. Refining clinical diagnosis with likelihood ratios. Lancet. 2005;365(9469):1500–1505. doi:https://doi.org/10.1016/S0140-6736(05)66422-7.
- Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. New York: Chapman and Hall; 1984.
- Lemon SC, Roy J, Clark MA, Friedman PD, Rakowski W. Classification and regression tree analysis in public health: methodological review and comparison with logistic regression. Ann Behav Med. 2003;26:172–181. doi:https://doi.org/10.1207/S15324796ABM2603_02.
- Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York, NY: Wiley; 2000.
- Tugal-Tutkun I, Gupta V, Cunningham ET. Differential diagnosis of Behçet uveitis. Ocul Immunol Inflamm. 2013;21:337–350. doi:https://doi.org/10.3109/09273948.2013.795228.
- Oray M, Onal S, Bayraktar S, Izgi B, Tugal-Tutkun I. Non-glaucomatous localized retinal nerve fiber layer defects in Behçet uveitis. Am J Ophthalmol. 2015;159:475–481. doi:https://doi.org/10.1016/j.ajo.2014.11.029.
- Okada AA, Stanford M, Tabbara K. Ancillary testing, diagnostic/classification criteria and severity grading in Behçet disease. Ocul Immunol Inflamm. 2012;20:387–393. doi:https://doi.org/10.3109/09273948.2012.723111.
- Tugal-Tutkun I, Onal S, Ozyazgan Y, Soylu M, Akman M. Validity and agreement of uveitis experts in interpretation of ocular photographs for diagnosis of Behçet uveitis. Ocul Immunol Inflamm. 2014;22:461–468. doi:https://doi.org/10.3109/09273948.2013.854393.
- Tugal-Tutkun I, Ozdal PC, Oray M, Onal S. Review for diagnostics of the year: multimodal imaging in Behçet uveitis. Ocul Immunol Inflamm. 2017;25:7–19. doi:https://doi.org/10.1080/09273948.2016.1205100.
- Matsuo T, Sato Y, Shiraga F, et al. Choroidal abnormalities in Behçet’s disease observed by simultaneous indocyanine green and fluorescein angiography with scanning laser ophthalmoscopy. Ophthalmology. 1999;106:295–300. doi:https://doi.org/10.1016/S0161-6420(99)90069-6.
- Klaeger A, Tran VT, Hiroz CA, et al. Indocyanine green angiography in Behçet’s uveitis. Retina. 2000;20:309–314. doi:https://doi.org/10.1097/00006982-200003000-00018.
- Bozzoni-Pantaleoni F, Gharbiya M, Pirraglia MP, Accorinti M, Pivetti-Pezzi P. Indocyanine green angiographic findings in Behçet disease. Retina. 2001;21:230–236. doi:https://doi.org/10.1097/00006982-200106000-00006.
- Atmaca LS, Sonmez PA. Fluorescein and indocyanine green angiography findings in Behçet’s disease. Br J Ophthalmol. 2003;87:1466–1468. doi:https://doi.org/10.1136/bjo.87.12.1466.
- Gedik S, Akova Y, Yilmaz G, et al. Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behcet’s disease. Ocul Immunol Inflamm. 2005;13:51–58. doi:https://doi.org/10.1080/09273940490518757.
- Onal S, Uludag G, Oray M, et al. Quantitative analysis of structural alterations in the choroid of patients with active Behçet uveitis. Retina. 2018;38:828–840. doi:https://doi.org/10.1097/IAE.0000000000001587.
- Kim M, Kim H, Kwon HJ, et al. Choroidal thickness in Behcet’s uveitis: an enhanced depth imaging-optical coherence tomography and its association with angiographic changes. Invest Ophthalmol Vis Sci. 2013;54:6033–6039. doi:https://doi.org/10.1167/iovs.13-12231.
- Ishikawa S, Taguchi M, Muraoka T, et al. Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Behçet’s disease. Br J Ophthalmol. 2014;98:1508–1513. doi:https://doi.org/10.1136/bjophthalmol-2014-305333.
- Shirahama S, Kaburaki T, Nakahara H, et al. Association between subfoveal choroidal thickness and leakage site on fluorescein angiography in Behçet’s uveitis. Sci Rep. 2019;9:8612. doi:https://doi.org/10.1038/s41598-019-45149-4.
- Kido A, Uji A, Morooka S, et al. Outer plexiform layer elevations as a marker for prior ocular attacks in patients with Behcet’s disease. Invest Ophthalmol Vis Sci. 2018;59:2828–2832. doi:https://doi.org/10.1167/iovs.18-24348.
- Khairallah M, Abroug N, Khochtali S, et al. Optical coherence tomography angiography in patients with Behçet uveitis. Retina. 2017;37:1678–1691. doi:https://doi.org/10.1097/IAE.0000000000001418.
- Somkijrungroj T, Vongkulsiri S, Kongwattananon W, Chotcomwongse P, Luangpitakchumpol S, Jaisuekul K. Assessment of vascular change using swept-source optical coherence tomography angiography: a new theory explains central visual loss in Behcet’s disease. J Ophthalmol. 2017;2017:2180723.
- Abucham-Neto JZ, Torricelli AAM, Lui ACF, Guimarães SN, Nascimento H, Regatieri CV. Comparison between optical coherence tomography angiography and fluorescein angiography findings in retinal vasculitis. Int J Retina Vitreous. 2018;4:15. doi:https://doi.org/10.1186/s40942-018-0117-z.
- Accorinti M, Gilardi M, De Geronimo D, Iannetti L, Giannini D, Parravano M. Optical coherence tomography angiography findings in active and inactive ocular Behçet disease. Ocul Immunol Inflamm. Sep27,2019; 1–12: doi:https://doi.org/10.1080/09273948.2019.1612452. [Epub ahead of print].
- Yazici H. Diagnostic versus classification criteria - a continuum. Bull NYU Hosp Jt Dis. 2009;67:206–208.